Supply Chain

Belgian Agri-Tech Firm Biotalys Plans Listing In Brussels

By Dayeeta Das
Share this article
Belgian Agri-Tech Firm Biotalys Plans Listing In Brussels

Belgian agri-tech company Biotalys announced on Tuesday plans to list on Euronext Brussels in the coming weeks, hoping to entice investors with its biological alternatives to chemical pesticides.

The company, founded in 2013, is a spin-off from the Flanders Institute for Biotechnology and the agricultural counterpart to Belgian biopharmaceutical firm Ablynx, which Sanofi bought in 2018 for €3.9 billion ($4.7 billion).

Both use llama antibodies, which are smaller and easier to manipulate than human equivalents. Biotalys extracts proteins for use against fungi, bacteria and insects that attack crops, especially high-value fruit like grapes and strawberries.

Chemical Pesticide

Biotalys expects to secure US regulatory approval in mid-2022 for its first product, Evoca, and sees a 2024 launch in the European Union, which aims to cut chemical pesticide use by 50% by 2030.

Biotalys has seven potential products it intends to launch over the next decade and estimates the market could be worth $4.8 billion as countries shift to greener forms of farming.


"That's why at Biotalys, we believe it's the right time to come out of the woods and to be really public and demonstrate the impact we can have to fulfil this requirement for innovation," Biotalys chief executive Patrice Selles said.

Research And Business Development

Selles declined to say how much money Biotalys planned to raise but said existing investors such as GIMV and Sofinnova Partners would participate in the flotation, proceeds of which would go towards research and business development.

New investors BNP Paribas and Belgian state fund SFPI-FPIM had also committed to a combined €10 million.

The company sees future revenues from its own sales and future partnerships and, longer term, use of its technology in other fields, such as food preservation.


Selles said Biotalys' products were as effective as chemical equivalents and superior to microbial solutions currently on the market because, as neutral proteins, they do not depend on particular environmental conditions to work.

News by Reuters, edited by ESM. For more Supply Chain news, click here. Click subscribe to sign up to ESM: European Supermarket Magazine.

Get the week's top grocery retail news

The most important stories from European grocery retail direct to your inbox every Thursday

Processing your request...

Thanks! please check your email to confirm your subscription.

By signing up you are agreeing to our terms & conditions and privacy policy. You can unsubscribe at any time.